BACKGROUND: Paraoxonase 1 (PON1), an esterase that hydrolyzes toxic organophosphates and has antioxidative and antiatherogenic properties, contains a common polymorphism at position 192: glutamine (Q) or arginine (R). The Q and R isoenzymes exhibit different physical and protective properties. We describe 2 methods for quantifying their serum activity levels.
Paraoxonase 1 (PON1, EC 3.1.8.1) 2 is a member of a unique, conserved family of calcium-dependent esterases (1 ) , predominantly synthesized in the liver and secreted into the blood, where it binds high-density lipoproteins (2 ) . PON1 hydrolyzes a range of esters including the oxon form of neurotoxic organophosphates (OPs), arylesters, and lactones, although its natural substrates are uncertain (1 ) . Through its ability to inactivate OPs, PON1 protects against OP-mediated neurotoxicity in animals (3 ) . Accumulating evidence suggests that it protects humans from neurotoxic effects of OPs (4 -7 ) . PON1 also protects low-density lipoproteins from oxidation and exerts anti-inflammatory and antiatherogenic effects, although the mechanisms for these effects are unclear (8, 9 ) . PON1 amounts vary widely in blood-more than 10-fold in the populationresulting in potential large differences in PON-mediated protective capacity (10 ) .
The hydrolytic efficiencies of PON1 with many substrates are strongly modulated by a single nucleotide polymorphism in the PON1 gene at position 192, where coding for the amino acid glutamine produces the Q isoenzyme and that for arginine produces the R isoenzyme (10 ) . The Q isoenzyme has a greater hydrolytic efficiency for, and more rapidly inactivates, OP chemical warfare nerve agents such as sarin and soman, whereas the R isoenzyme has greater hydrolytic efficiency for, and thus more rapidly inactivates, certain OP pesticides, such as paraoxon and chlorpyrifosoxon; both isoenzymes hydrolyze phenylacetate with similar efficiency (11, 12 ) . The R isoenzyme hydrolyzes many lactones, some of which are potential physiological substrates, with higher efficiencies than the Q isoenzyme (13 ) . Consequently, there has been substantial research investigating the association of Q192R genotypes with differences in susceptibility to both immediate and long-term effects of OP poisoning and cardiovascular complications of atherosclerosis (14, 15 ) . Along with Q192R polymorphic form, however, the level of protection from diseases is strongly influenced by the amount of PON1 protein produced, which is influenced by other genetic, environmental, and pathological factors (16 ) . Consequently, measurements of serum hydrolytic activity levels of the Q and R isoenzymes, which capture differences due to both the polymorphic forms and the protein concentrations, should be more strongly associated with diseases than the Q192R gene polymorphism alone (17 ) . Previous studies suggest that serum activity levels of PON1 Q and R isoenzymes in QR heterozygotes are not always equal (half isoenzyme Q and half isoenzyme R). In fact, the ratio of the two isoenzymes in serum appears to vary considerably from a 1:1 mixture in many QR heterozygotes (18 ) .
Although all serum PON1 hydrolytic activity in QQ homozygotes is of the Q isoenzyme type and all in RR homozygotes is of the R isoenzyme type, no method has been described for determining the relative amounts of each isoenzyme in QR heterozygotes. Fundamental to this determination is the observation of La Du et al. (18 ) that the bivariate plot of serum PON1 arylesterase (AE) activity (i.e., rate of phenylacetate hydrolysis) and serum PON1 paraoxonase (PXN) activity (i.e., rate of paraoxon hydrolysis) defines 3 phenotypic groups that correspond closely with the 3 Q192R genotypes: QQ, QR, and RR. From that observation, it follows that the PXN/AE activity ratio can be used as an interpolation index to estimate the relative amounts of total PON1 hydrolytic activity attributable to each of the Q and R isoenzymes in QR heterozygous individuals (18 ) . We previously described a successful application of this method but did not describe the method in detail (19 ) . Subsequently, Richter and Furlong (20 ) established that the use of serum PON1 diazoxonase (DZN) activity (i.e., rate of diazoxon hydrolysis) instead of AE activity in the bivariate plot provides more precise PON1 phenotyping, suggesting that it might also provide more precise estimation of isoenzyme activity levels. Here we describe for the first time the method for estimating Q192R isoenzyme activity levels by linear interpolation from the PXN/AE ratio (method 1) and by a new approach on the basis of nonlinear interpolation from the PXN/DZN ratio (method 2), both tested with serum and DNA from a large population sample.
Materials and Methods

STUDY POPULATION
The study population consisted of 2095 veterans [mean age 46.5 years (range 34 -76); 16% women] selected as a representative sample of the 1991 US military population who participated in the US Military Health Survey (21, 22 ) . The population had relatively low rates of common conditions such as diabetes (10.3%), heart disease (7.7%), liver disease (2.2%), and obesity (body mass index Ͼ35) (10.5%). Blood was collected by phlebotomists and mailed overnight at 4°C to our laboratory. We isolated genomic DNA from buffy coats with the Gentra Purgene Blood Kit (Qiagen) and stored serum and DNA at Ϫ80°C.
ENZYMATIC ASSAYS
Phenylacetate was from Sigma-Aldrich. Paraoxon and diazoxon (Chem Service) were prepared as stocks, 200 mmol/L in methanol and acetonitrile, respectively, and stored at Ϫ80°C. We adapted enzymatic assays from those previously described (11, 20 ) .
Buffers were filtered with a 0.22-m filter. We performed serum dilutions and enzymatic assays in 96-well plates on a BioTek Precision XS automated pipetting station equipped with a Twister II microplate handler and a BioTek Synergy HT microplate spectrophotometer. Serum was thawed at room temperature, briefly vortex-mixed, centrifuged at 10 000g for 2 min at 4°C, diluted 1:10 with 5 mmol/L Tris-HCl, pH 7.4, containing 1 mmol/L CaCl 2 , and thoroughly mixed. Paraoxon and diazoxon stock solution concentrations were verified by HPLC analysis before use.
For AE activity, we further diluted the sample (1: 40) in 50 mmol/L Tris-HCl, pH 8.0, and 1 mmol/L CaCl 2 and transferred 10 L sample to a UV microplate. We diluted a 10.5-mmol/L phenylacetate solution in water (made fresh and thoroughly mixed) in 50 mmol/L Tris-HCl, pH 8.0, and 1 mmol/L CaCl 2 (final phenylacetate concentration 1.0 mmol/L) and added 190 L to the wells containing the diluted serum. The microplate was shaken for 3 s, and absorbance (A) was read at 270 nm.
For PXN activity, we transferred 20 L diluted serum to a microplate. We diluted a 200-mmol/L paraoxon stock solution (in methanol) to 1.32 mmol/L in 100 mmol/L Tris-HCl, pH 8.5, 1 mmol/L CaCl 2 , and 2 mol/L NaCl (final paraoxon concentration 1.2 mmol/ L). After thorough mixing, 180 L was added to the wells containing the diluted serum. The microplate was shaken for 3 s, and A was read at 405 nm.
For DZN activity, we transferred 10 L diluted serum to a microplate. We diluted a 200-mmol/L diazoxon stock solution (in methanol) to 1.05 mmol/L in 100 mmol/L Tris-HCl, pH 8.5, 1 mmol/L CaCl 2 , and 2 mol/L NaCl (final diazoxon concentration 1.0 mmol/L) and added 190 L diazoxon solution to the wells containing the diluted serum. The microplate was shaken for 3 s, and A was read at 270 nm.
For each assay, As were read every 14 s for 5 min. The pathlength was normalized to 1 cm with the pathlength correction parameter on the reader. We measured the ini-tial rate of substrate hydrolysis from the maximum of the slope (A/min) over a 10-reading interval with extinction coefficients of 1310, 3000, or 17 000 L ⅐ mol Ϫ1 ⅐ cm Ϫ1 for the AE, DZN, and PXN assays, respectively. Samples were run in triplicate, and a blank and a QC serum sample were run with each plate to ensure accuracy.
In performing the activity assays on the samples, the interassay CVs from the repeat testing of the control sample in every batch were 4.9%, 4.0%, and 3.4% for AE, DZN, and PXN activities, respectively, and the intraassay CVs among the 3 triplicate runs of each sample were 5.2%, 2.7%, and 1.4%.
GENOTYPING
Genotyping was performed in a 96-well plate format on a Bio-Rad iQ5 Real-Time PCR Detection System with the Taqman SNP genotyping/allelic discrimination assay per the manufacturer's protocol (Applied Biosystems). Labeled primers and probes for the PON1 Q192R genotyping assay were designed, manufactured, and validated by Applied Biosystems. All samples were run in triplicate, and each plate had a negative control and a QC (PON1 type 192 QR) sample.
SERUM MIXTURES FOR EQUATION DERIVATION
To derive the interpolation equation for estimating %Q isoenzyme activity (method 2) from the PXN/ DZN ratios, we selected 10 homozygous QQ samples (5 white and 5 black subjects) and 10 homozygous RR samples (5 white and 5 black subjects) in race-matched pairs so that QQ and RR members of each pair had approximately equal AE activity levels, i.e., equal levels of total PON1 hydrolytic activity (see Supplemental  Table 1 , which accompanies the online version of this article at http://www.clinchem.org/content/vol59/ issue8). For each of the 10 matched pairs, sera from the 2 subjects were mixed in calculated proportions to produce 11 mixtures with percentages of the Q isoenzyme of 0%, 10%, . . . 100%, resulting in 110 mixture aliquots. Each mixture aliquot was assayed for DZN and PXN activities, and the PXN/DZN ratio was calculated. By multiple linear modeling analyses, we found that %Q was strongly associated with log-transformed PXN/DZN ratio and that the strength of the association did not differ significantly between black and white subjects or across the levels of total PON1 activity. We therefore averaged the PXN/DZN ratios across race and levels of total PON1 activity to obtain a mean PXN/DZN ratio for each of the 11 %Q activity categories for analysis.
DATA ANALYSIS
Curve fitting, interpolation, and statistical analysis were performed with SAS (version 9.2, SAS Institute), SigmaPlot, and GraphPad Prism 5 software.
Results
PHENOTYPING WITH SERUM ACTIVITY RATIOS
We identified the PON1 Q192R phenotype of each of the sera from the bivariate distribution plot of PXN and AE activities and the PXN/AE ratio (Fig. 1, A and B) as previously described (18, 19 ) . We repeated the phenotyping as described by Richter and Furlong (20 ) , plotting activity levels of PXN and DZN and the PXN/DZN ratio (Fig. 1, C and D) . Whereas both techniques provide clear separation between the QQ and QR phenotypic groups, the PXN/DZN ratio provides greater separation between the QR and RR phenotypes (Fig. 1D) than the PXN/AE ratio (Fig. 1B) .
The Q192R phenotypes determined by the 2 techniques agreed almost perfectly ( ϭ 0.997), with disagreement on only 4 (0.2%) of the samples ( Table 1) . The phenotypes of both techniques also agreed strongly with the PCR-determined genotypes, with disagreement on 42 (2.0%) of the samples by use of the PXN/AE ratios and 44 (2.1%) by PXN/DZN ratios (Table 2). The QR genotype/RR phenotype was by far the most common discordance by both methods. These discordant samples are thought to reflect functionaltering allelic mutations (23 ) .
ESTABLISHING A MEASURE OF TOTAL PON1 HYDROLYTIC ACTIVITY
At a phenylacetate concentration of 1 mmol/L, the mean specific activities (micromoles of substrate hydrolyzed per milligram of PON1 protein) of PON1 type Q and R isoenzymes for phenylacetate (i.e., AE activity) are essentially the same (11 ) . Therefore, AE activity can be used as a measure of total PON1 activity across a population, irrespective of genotype. Conversely, serum PXN and DZN activities are influenced by both PON1 protein concentrations and Q192R genotype. This is exemplified in the 2095 sera, in which mean AE activity levels did not differ significantly across the phenotypic groups, but mean PXN and DZN activity levels did (Fig. 2 ).
METHOD 1: ESTIMATION OF %Q IN QR HETEROZYGOTES FROM PXN/AE
Because AE specific activity is constant across Q192R genotypes, in QR heterozygotes the relationship between %Q and the PXN/AE ratio is linear. To derive an interpolation equation for estimating %Q from the PXN/AE ratio, we first calculated the mean PXN/AE activity ratio in the 835 QQ homozygous sera [mean (SD) 2.165 (0.366)] of our study population, in which %Q is by definition 100%, and in the 332 RR homozygous sera [10.476 (0.731)], in which %Q is by definition 0%, and fitted the following linear function to the 2 points (Fig. 3A) :
where y is the %Q and x is the serum PXN/AE ratio.
We estimated the %Q by applying Eq. 1 to the PXN/AE ratios of the 925 QR heterozygous samples, producing a relatively smooth, symmetrical distribution with a median value of 49.0% (Fig. 4A) . We estimated %R in each sample by subtracting %Q from 100, thus producing the mirror image distribution to that of %Q, with a median value of 51.1% (Fig. 4A) . The QR heterozygous samples with a putative function-altering allele mutation of the Q or R allele produced small secondary peaks between 0% and 20% and between 70% and 100%.
METHOD 2: ESTIMATION OF %Q IN QR HETEROZYGOTES FROM PXN/DZN
Because the specific activities of both PXN and DZN differ across the Q192R genotypes, serum PXN and DZN activity will change with total PON1 protein con- Serum AE, PXN, and DZN activities were measured by serum hydrolytic activity against phenylacetate, paraoxon, and diazoxon, respectively. Using the PXN/AE activity ratios, the phenotypes QQ, QR, and RR are evident in the plot of AE by PXN (A), and the phenotypes were determined by cutpoints at 3.0 and 8.7 in the PXN/AE ratio (B). Using the PXN/DZN activity ratios, the phenotypes QQ, QR, and RR are evident in the plot of DZN by PXN (C), and the phenotypes were determined by cutpoints at 0.03 and 0.10 in the PXN/DZN ratio (D). Phenotypes QR and RR were more widely separated by the PXN/DZN activity ratio than by the PXN/AE activity ratio. In (A) and (C), 42 and 44 observations, respectively, have phenotypes inconsistent with their genotypes; these are thought to represent allele mutations that altered the isoenzyme activity or concentration, as described by Jarvik et al. (23 ) .
centration and relative amounts of the type Q and R isoenzymes in a sample. Thus, the function describing the relationship of %Q with the PXN/DZN ratio is nonlinear ( Fig. 3B ) and must be determined empirically. To define this function, we fitted a family of polynomial functions to the plot of %Q activity on the 11 mean PXN/DZN ratios of the 110 mixture aliquots and found the best fit to be the following cubic polynomial function (R 2 ϭ 0.9999) (Fig. 3B) :
where y is the %Q and x is the serum PXN/DZN ratio. We estimated the %Q for each of the 925 QR heterozygous samples in the study population by applying Eq. 2 to their PXN/DZN ratios, producing a more complex, multimodal distribution than that of PXN/AE, with a median value of 46.9% (Fig. 4B) . The small secondary peaks from the QR heterozygotes with a putative function-altering allele mutation of the Q or R allele again appeared between 0% and 20% and between 70% and 100%. We estimated %R in each sample by subtracting %Q from 100, thus producing the mirror image distribution to that of %Q, with a median value of 53.1% (Fig. 4B) .
For both methods, the final %Q for all QQ homozygous samples was assigned, by definition, the value of 100%, and the %Q for all RR homozygous samples, 0%.
Q AND R ISOENZYME ACTIVITY LEVELS
In each of the 2095 samples, the Q isoenzyme activity level (Fig. 4 , D and E) was estimated by the product of %Q/100, determined by either method, and the AE activity (total PON1 hydrolytic activity) (Fig. 4C ). The R isoenzyme activity level was then obtained by subtracting the estimated Q isoenzyme activity from the AE activity (total PON1 activity).
The Q and R isoenzyme activity levels of the 925 QR heterozygotes estimated by the 2 methods had similar distributions (Fig. 4, D and E ). Both featured a small peak between 0 and 20 U/mL and other peaks Ͼ100 U/mL, reflecting the samples with putative function-altering allele mutations. The final estimates of Q and R isoenzyme activity values obtained in the 925 QR heterozygotes by the 2 methods agreed closely (intraclass correlation coefficient ϭ 0.94).
In the QR heterozygotes, the percentage of total PON1 activity due to the Q isoenzyme ranged from 0% to 100%, and after exclusion of the few genotype/ phenotype-discordant samples, from 22% to 70% (Fig.  4, A and B) .
STABILITY OF THE INTERPOLATION IN DISEASE
To assess the stability of the interpolation across different disease conditions, we developed a multivariable linear model in the 1162 QQ and RR homozygous subjects, predicting %Q activity with the PXN/AE ratio, the indicator of a given disease, and their interaction, where a significant interaction would indicate a different interpolation function in people with the disease. The interactions were nonsignificant for diabetes (n ϭ 122, P int ϭ 0.68), heart disease (n ϭ 89, P int ϭ 0.78), liver disease (n ϭ 37, P int ϭ 0.75), and body mass index Ͼ35 (n ϭ 119, P int ϭ 0.68). It should be noted that our study population is relatively young and healthy. Whether more severe disease states, particularly those that alter or damage high-density lipoproteins, affect the derived equations is not known and will require a Cut points at 0.03 and 0.10 ( Fig. 1D) . b Cut points at 3 and 8.7 (Fig. 1B) . studies in which more severely diseased and healthy populations are compared.
Discussion
MAIN FINDINGS ON 2 METHODS OF DETERMINING Q AND R ACTIVITY
We describe the development of 2 novel methods for determining the hydrolytic activity levels of the PON1 Q and R isoenzymes in QR heterozygous serum samples. Both methods can be applied by use of standard PON1 assays and substrates. Both methods yield approximately the same estimates of Q and R isoenzyme activity levels, as evidenced by similar distributions and a very high intraclass correlation coefficient (0.99). The main advantage of the use of the PXN/DZN ratio over the PXN/AE ratio is in phenotyping samples, where PXN/DZN provides wider separation of the QQ and QR phenotypes, as previously demonstrated (20 ) . However, with our precise automated system for enzymatic analysis, this apparent advantage made little difference in the phenotypic classification in our large sample. We conclude that the 2 enzyme ratios and interpolation methods are equally useful, in both phenotyping samples and estimating Q and R isoenzyme activity levels.
WIDE RANGE OF ISOENZYME ACTIVITY LEVELS
In the QR heterozygotes, the %Q ranged from 0% to 100%, and after exclusion of the few genotype/ phenotype-discordant samples, it still ranged from 22% to 70%. This confirms the wide deviation from an equal 1:1 mixture of Q and R isoenzyme activities in heterozygotes previously suggested (18 ) . The factors that contribute to unequal levels of the 2 isoforms are uncertain. Unequal expression of allelic copies in autosomal nonimprinted genes is a common occurrence in humans (24 ) . Studies have also suggested that the greater stability of the R isoenzyme could contribute to its higher levels in some QR heterozygotes (13 ) .
PUTATIVE ALLELE MUTATIONS
The multimodal shape of the Q and R isoenzyme activity distributions (Fig. 4) suggests the presence of several function-altering PON1 allele mutations in the study population. The small, discrete peaks between 0 and 20 U/mL and Ͼ100 U/mL (Fig. 4, D premature stop codon in the R allele in the QR genotype/QQ phenotype subject. Upon sequencing of the PON1 gene region in the 4 QR genotype/RR phenotype mismatches, 1 appeared to have a deletion in a region of the gene; no other coding region changes were detected in the other 3 discordant individuals. Our finding in this large population-representative sample suggests a rate of genotype/phenotype mismatches perhaps 3 times higher. We also observed low rates of QQ genotype/QR phenotype and RR genotype/QR phenotype mismatches, not observed by Jarvik et al. (23 ) . This suggests potentially rare mutations in Q and R alleles that alter the binding and/or kinetics of hydrolysis of 1 of the tested organophosphate substrates but not the other. In addition to the genotype/phenotype mismatches, we found other peaks and shoulders within the main distributions of the Q and R isoenzymes, between 25 and 100 U/mL (Fig. 4, D and E) , suggesting other factors that only partially altered the specific activity of one of the isoenzymes in subpopulations of QR heterozygotes. These changes could result from uncommon allelic mutations or factors extrinsic to PON1, such as alterations in high-density lipoprotein composition or structure.
APPLICATIONS AND LIMITATIONS OF THE METHODS
These methods of quantifying the levels of hydrolytically active PON1 Q and R isoenzymes will provide a unique and valuable tool for studying the susceptibility of QR heterozygous individuals to the toxic effects of organophosphates that are hydrolyzed with different efficiencies by the Q and R isoenzymes (11, 12 ) . However, these methods may apply only to the study of functions of PON1 mediated by its hydrolytic activity (e.g., protection from OP toxicity). It is presently not clear whether, or to what extent, properties of PON1 such as its antioxidative, reverse cholesterol transport, and anti-inflammatory functions are related to its hydrolytic activity. PON1 can become hydrolytically inactivated by loss of its embedded calcium, oxidative damage, and potentially other mechanisms (25, 26 ) . Whether inactivation of PON1 hydrolytic activity reflects inactivation of its other functions is unknown. Furthermore, there is considerable uncertainty about the extent to which PON1 may protect against diseases of which oxidative stress and inflammation are etiologic factors and whether there are differences between the Q and R isoenzymes in these protective capacities.
Early in vitro studies suggested that the Q isoenzyme was a better antioxidant; however, recent in vitro studies suggest that the R isoenzyme is better at reverse cholesterol transport and more stable than the Q isoenzyme (13, 27 ) . A recent large clinical study also suggests that the R isoenzyme is better at limiting oxidative damage and cardiovascular disease risk (28 ) . Estimating Q and R isoenzyme activity levels by the described interpolation methods will allow a more thorough comparison than previously possible of the association of hydrolytically active PON1 and its isoenzymes with disease measures. Such comparisons in clinical studies should help determine which protective functions of PON1 require a hydrolytically active protein and (A), PXN/AE ratios of the QQ homozygous subjects (n ϭ 885) in the national veterans sample were averaged, as were those of the RR homozygous subjects (n ϭ 334). Given that %Q is 100% in the QQ homozygotes and 0% in the RR homozygotes, a linear regression function was fitted to the 2 points to form an interpolation function for method 1. (B), Each serum pair, matched for race and total PON1 hydrolytic activity, was mixed in varying proportions to form 110 mixture aliquots with %Q levels from 0% to 100%. PXN and DZN activity levels of each mixture were measured, and PXN/DZN ratios for each of the 110 %Q levels were averaged. The 110 %Q values were regressed on their mean PXN/DZN ratios, and the cubic polynomial was found to give the best fit. Fig. 4 . Distributions of %Q and %R, total serum PON1 hydrolytic activity, and Q and R isoenzyme activities in the QR heterozygous subjects.
The %Q and %R were generated by method 1 (A) and method 2 (B). (C), Distribution of total serum PON1 hydrolytic activity (AE activity). Q and R isoenzyme activity was obtained by multiplying total PON1 hydrolytic activity by %Q or %R with method 1 (D) and method 2 (E).
whether the PON1 192 Q and R isoenzymes exhibit different protective capacities. 
Role of Sponsor:
The funding organizations played no role in the design of study, choice of enrolled patients, review and interpretation of data, or preparation or approval of manuscript.
